← Open Payments lookup

ERICA TIDIANE: Open Payments

NPI 1205407095 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,438 in 62 payments from 15 companies in 2025. Trend: 2023 $713 · 2024 $2,078 · 2025 $1,438

Food & beverage: $1,438
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$186
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$164
Neuronetics, Inc.3$158
ABBVIE INC.8$140
Otsuka America Pharmaceutical, Inc.5$115
Teva Pharmaceuticals USA, Inc.4$102
Janssen Pharmaceuticals, Inc4$94
Tris Pharma Inc4$88
Bausch Health US, LLC4$88
Lundbeck LLC3$72

Products named: REXULTI, INGREZZA, CAPLYTA, NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, AUSTEDO XR, SPRAVATO, Dyanavel XR.

Industry payments across CA — which companies pay providers there.